Breakthrough development Reported in vaccine against the novel coronavirus
ISLAMABAD - Breakthrough development Reported in vaccine against the novel coronavirus.
With over 90 vaccines link in the works around the world, various medical institutions and biotech companies are in hot pursuit of creating a vaccine that delivers promising results in the test subjects.
Currently, there are 8 vaccines around the world that are being tested on human subjects. However, only a few major developments have been made public on that front. As per the recent reports, USA, UK, and China might actually be on to a major breakthrough on the coronavirus vaccine development. *In the US, Moderna’s Vaccine has shown Promising Results*
On 18th of May 2020, a US-based biotech firm Moderna link announced that their vaccine elicited an immune response among the human test subjects, and also protected the mice from developing SARS-CoV-2 symptoms.
The vaccine is being co-developed with the US National Institute of Allergy and Infectious Disease (NIAID) in Bethesda, Maryland.
Since the news broke, it is being reported that the company has seen a significant rise in its stock market figures. Along with that, the company has also received $483 million from a federal agency to catalyze the development of the vaccine. ------------------------------ *In the UK, Oxford University’s Vaccine has sparked Hope*
In the UK, the University of Oxford link has also reportedly been developing a vaccine. The said vaccine resulted in six monkeys getting rid of the COVID-19 induced pneumonia.
However, the rest of the organs, especially the nose of the animals, seemed to display the same levels of viral infection as the unvaccinated animals. Still, the institute is pressing on with the human trials.
It is also being reported that if everything falls into place, the UK citizens shall have access to 30 million doses of the vaccine by the month of September this year. *China’s Sinovac Biotech has shown Positive Immunity Response*
Likewise, the Chinese Biotech firm known as Sinovac Biotech link has also been working on a vaccine that has seemingly stimulated a relatively more positive immunity response amongst the macaques that received three doses.
That vaccine is constituted of chemically incapacitated SARS-CoV-2 particles that boost the immunity to the virus within the subjects. Ever the diplomats, China has proclaimed that the vaccine, as and when it becomes available, shall be promoted as a public good, which according to the experts, is China’s display of generosity towards the international community, contrary to the notions of the US and the European community.